Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000071633-97-000002
Filing Date
1997-04-07
Accepted
1997-04-07 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 13634
  Complete submission text file 0000071633-97-000002.txt   15641
Mailing Address 51 MADISON AVE ROOM 207 ATTN INVESTMENT DEPT VENTURE CAP GROUP NEW YORK NY 10010
Business Address 51 MADISON AVE ROOM 207 ATTN INVESTMENT DEPT VENTURE CAP GROUP NEW YORK NY 10010 2125767643
NEW YORK LIFE INSURANCE CO (Filed by) CIK: 0000071633 (see all company filings)

EIN.: 135582869 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 81 DIGITAL DR NOVATO CA 94949
Business Address 81 DIGITAL DR NOVATO CA 94949 4153826653
GLYKO BIOMEDICAL LTD (Subject) CIK: 0000908401 (see all company filings)

EIN.: 680230537 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50741 | Film No.: 97575423
SIC: 2835 In Vitro & In Vivo Diagnostic Substances